HANNAH ALISON L. — SEC Form 4 filings
SEC reporting owner CIK 1645600. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-29 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEOGENOMICS INC (NEO) | Director | 4 | — | — | 9 |
| RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Medical Officer | 4 | — | — | 6 |
Form 4 filings — HANNAH ALISON L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 24,400 @ $0 | EDGAR |
| 2026-05-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 5,750 @ $0 | EDGAR |
| 2025-06-03 | 4/A | NEOGENOMICS INC (NEO) | Option exercise (M): 12,254 @ $0 | EDGAR |
| 2025-06-03 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 12,254 @ $0 · Option exercise (M): 12,254 (derivative) @ $0 · Grant/award (A): 16,107 (derivative) @ $0 · Grant/award (A): 23,077 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 2,500 @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 11,336 @ $0 · Option exercise (M): 11,336 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 8,672 (derivative) @ $0 · Grant/award (A): 12,254 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1645600 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →